Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 1, 2013, Pages 171-178

  Peter, Franziska ^a   Wittekindt, Claus ^a,b   Finkensieper, Mira ^a   Kiehntopf, Michael ^a   Guntinas Lichius, Orlando ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Blood value; Head neck cancer; Outcome; Prognostic marker; Serology; Survival

Indexed keywords

C REACTIVE PROTEIN; LIVER ENZYME; UREA;

ADULT; AGED; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; HEAD AND NECK CANCER; HUMAN; LABORATORY TEST; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; BLOOD CELL COUNT; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMORBIDITY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER FUNCTION TESTS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 84872300493     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1320-1     Document Type: Article

References (23)

1. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945-1952
2. Bleeker JS, Hogan WJ (2011) Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies. Thrombosis 2011:536062. doi: 10.1155/2011/536062
3. Chapireau D, Adlam D, Cameron M, Thompson M (2010) Paraneoplastic syndromes in patients with primary oral cancers: a systematic review. Br J Oral Maxillofacial Surg 48(5):338-344
4. Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF (2011) Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol 36(2):147-153
5. Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ (2010) Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 32(6):728-736
6. D'Hoore W, Sicotte C, Tilquin C (1993) Risk adjustment in outcome assessment: the Charlson comorbidity index. Meth Inform Med 32(5):382-387
7. Gaudet MM, Olshan AF, Chuang SC, Berthiller J, Zhang ZF, Lissowska J, Zaridze D, Winn DM, Wei Q, Talamini R, Szeszenia-Dabrowska N, Sturgis EM, Schwartz SM, Rudnai P, Eluf-Neto J, Muscat J, Morgenstern H, Menezes A, Matos E, Bucur A, Levi F, Lazarus P, La Vecchia C, Koifman S, Kelsey K, Herrero R, Hayes RB, Franceschi S, Wunsch-Filho V, Fernandez L, Fabianova E, Daudt AW, Dal Maso L, Curado MP, Chen C, Castellsague X, Benhamou S, Boffetta P, Brennan P, Hashibe M (2010) Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol 39(4):1091-1102
8. Gimeno-Hernandez J, Iglesias-Moreno MC, Gomez-Serrano M, Carricondo F, Gil-Loyzaga P, Poch-Broto J (2011) The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma. Acta Otolaryngol 131(8):840-846
9. Greve J, Schuler PJ, Bas M, Adamzik M, Brandau S, Arweiler-Harbeck D, Lang S, Hoffmann TK (2010) Coagulation factors as potential tumour markers in patients with head and neck carcinomas? Laryngorhinootol 89(10):612-615
10. Guntinas-Lichius O, Wendt T, Buentzel J, Esser D, Lochner P, Mueller A, Schultze-Mosgau S, Altendorf-Hofmann A (2010) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136(1):55-63
11. Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R (2009) Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 45(10):912-914
12. Kruse AL, Luebbers HT, Gratz KW (2010) C-reactive protein levels: a prognostic marker for patients with head and neck cancer? Head Neck Oncol 2:21
13. Kruse AL, Luebbers HT, Gratz KW (2011) Evaluation of white blood cell count as a possible prognostic marker for oral cancer. Head Neck Oncol 3:13
14. Lee L, Cheung WY, Atkinson E, Krzyzanowska MK (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29(1):106-117
15. Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ (2007) Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol 43(3):283-288
16. Mell LK, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR (2010) Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28(1):15-20
17. Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17(4):340-344
18. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. New Engl J Med 357(17):1705-1715
19. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK (2011) Population-based study of competing mortality in head and neck cancer. J Clin Oncol 29(26):3503-3509
20. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP (2007) Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 14(4):1449-1457
21. Toro C, Rinaldo A, Silver CE, Politi M, Ferlito A (2010) Paraneoplastic syndromes in patients with oral cancer. Oral Oncol 46(1):14-18
22. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA (2006) The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol 42(2):131-138
23. Yung KC, Piccirillo JF (2008) The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Arch Otolaryngol Head Neck Surg 134(10):1045-1049